Erratum: Phase 3 Trial of a Small-Volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty (The Journal of Clinical Endocrinology and Metabolism (2020) 105:10 (e3660-e3671) DOI: 10.1210/clinem/dgaa479)

K. O. Klein, A. Freire, M. G. Gryngarten, G. B. Kletter, M. Benson, B. S. Miller, T. S. Dajani, E. A. Eugster, N. Mauras

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the above-named article by Klein KO, Freire A, Gryngarten MG, Kletter GB, Benson M, Miller BS, Dajani TS, Eugster EA, and Mauras N (J Clin Endocrinol Metab. 2 020;105(10):e3660-e3671; doi: 10.1210/clinem/dgaa479), the following errors occurred in the article as first published. On page e3663, in the sentence "Approximately half were Caucasian (32/62; 51.6%), with the remainder being African American or other ethnic minorities," and in Table 1, the word "Caucasian" appeared instead of "White." The corrected sentence reads "Approximately half were White (32/62; 51.6%), with the remainder being African American or other ethnic minorities." On page e3664, in the sentence "Mean random LH levels were =0.6 IU/L and ranged from 0.1 to 3.9 IU/L across all timepoints after week 12" the value 3.9 IU/L was provided for the upper limit of the range instead of 3.3 IU/L. The corrected sentence is "The mean random LH across all timepoints after week 12 was >0.6 IU/L and ranged from 0.1 to 3.3 IU/L." On page e3664, in the sentence "Among the other 7 girls who completed the study, 4 had peak LH levels between 4.2 and 4.8 IU/L at week 24, with similar values at week 48 (range: 4.1- 6.1)," the range "(range: 4.1 6.1)" was provided instead of "(range: 3.8 to 6.1)." The corrected sentence reads "Among the other 7 girls who completed the study, 4 had peak LH levels between 4.2 and 4.8 IU/L at week 24, with similar values at week 48 (range: 3.8 - 6.1)," On page e3664, in the sentence "90% (54/60) of girls at week 24 and 98% (55/56) at week 48 achieved E2 >10 pg/mL. " the percentage "98% (55/56)" appeared instead of "88% (49/56)." The corrected sentence reads "90% (54/60) of girls at week 24 and 88% (49/56) at week 48 achieved E2 >10 pg/mL. " In Table 1, mean BMI was reported as 18.5. The correct value is 18.6. The table should read: (Formula present) On page e3665, the sentence "Mean BMI at baseline was 18.2 0.4 kg/m2 (median: 18.6; range: 13.9 25.3). BMI increased slightly from baseline to week 24 (18.8 0.4 kg/m2; median: 19.1; range: 12.9 27.2; P > .01) but did not significantly increase between week 24 and week 48 (19.1 0.4 kg/ m2; median: 19.7; range: 13.4 to 27.4; P = .16)" included incorrect data. The corrected sentence is "Median BMI at baseline was 18.2 kg/m2 (mean: 18.6 0.4 kg/m2). BMI showed a small increase from baseline to week 24 (week 24 mean 19.1 kg/m2, p>0.01, median 18.8 kg/m2) and to week 48 (week 48 mean 19.7 kg/m2, p>0.01, median 19.3 kg/m2)." The authors state that the changes do not affect the interpretation or conclusions of the article. All the changes have been incorporated in the article online. doi: 10.1210/clinem/dgaa479.

Original languageEnglish (US)
Pages (from-to)E2842
JournalJournal of Clinical Endocrinology and Metabolism
Volume106
Issue number7
DOIs
StatePublished - Jul 1 2021

Bibliographical note

Publisher Copyright:
© 2021 Endocrine Society. All rights reserved.

Fingerprint

Dive into the research topics of 'Erratum: Phase 3 Trial of a Small-Volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty (The Journal of Clinical Endocrinology and Metabolism (2020) 105:10 (e3660-e3671) DOI: 10.1210/clinem/dgaa479)'. Together they form a unique fingerprint.

Cite this